1. Home
  2. EEIQ vs VIVS Comparison

EEIQ vs VIVS Comparison

Compare EEIQ & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$3.84

Market Cap

3.4M

Sector

Real Estate

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$1.28

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEIQ
VIVS
Founded
2017
2007
Country
United States
United States
Employees
N/A
9
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
3.9M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
EEIQ
VIVS
Price
$3.84
$1.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
244.0K
27.2K
Earning Date
01-28-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$1.22
52 Week High
$12.70
$5.30

Technical Indicators

Market Signals
Indicator
EEIQ
VIVS
Relative Strength Index (RSI) 54.61 34.84
Support Level $3.59 $1.24
Resistance Level $4.67 $1.38
Average True Range (ATR) 0.62 0.06
MACD 0.14 0.01
Stochastic Oscillator 44.06 29.03

Price Performance

Historical Comparison
EEIQ
VIVS

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S, Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. The Company's revenue is derived from foreign education programs, university education programs and student accommodation services.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: